Drugs / Bicifadine
Bicifadine
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00597649 | Oct 2007 → Dec 2008 | diabetic polyneuropathy | XTL Biopharmaceuticals | Terminated | No outcome recorded |
| Phase 2 | NCT00553592 | Sep 2007 → Dec 2008 | diabetic polyneuropathy | XTL Biopharmaceuticals | Unknown | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT00295724 | Oct 2005 → ? | chronic pain syndrome | DOV Pharmaceutical, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00281645 | Dec 2004 → ? | chronic pain syndrome | DOV Pharmaceutical, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00295711 | Sep 2004 → ? | chronic pain syndrome | DOV Pharmaceutical, Inc. | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bicifadine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00597649 ↗ |
| Known as | Bicifadina | ChEMBL registry synonym — accepted as the source's own label CHEMBL511099 ↗ |
| Known as | Bicifadine hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL511099 ↗ |
| Known as | BICIFADINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL511099 ↗ |
| Known as | CL 220,075 | ChEMBL registry synonym — accepted as the source's own label CHEMBL511099 ↗ |
| Modality | Small molecule | — CHEMBL511099 ↗ |
| Route | Oral | “bicifadine at three oral dose levels compared with placebo” NCT00295711 ↗ |